| Primary |
| Attention Deficit/hyperactivity Disorder |
95.0% |
| Overdose |
5.0% |
|
| Feeling Abnormal |
13.8% |
| Death |
6.9% |
| Headache |
6.9% |
| Hyperhidrosis |
6.9% |
| Product Quality Issue |
6.9% |
| Product Substitution Issue |
6.9% |
| Somnolence |
6.9% |
| Cardio-respiratory Arrest |
3.4% |
| Drug Ineffective |
3.4% |
| Fatigue |
3.4% |
| Irritability |
3.4% |
| Logorrhoea |
3.4% |
| Rash |
3.4% |
| Sleep Disorder |
3.4% |
| Tablet Issue |
3.4% |
| Tachycardia |
3.4% |
| Thirst |
3.4% |
| Tic |
3.4% |
| Visual Impairment |
3.4% |
| Vomiting |
3.4% |
|
| Secondary |
| Product Used For Unknown Indication |
44.0% |
| Drug Use For Unknown Indication |
39.4% |
| Suicide Attempt |
3.1% |
| Schizophrenia |
2.2% |
| Drug Abuse |
1.8% |
| Drug Abuser |
1.7% |
| Ill-defined Disorder |
1.7% |
| Antiretroviral Therapy |
1.5% |
| Drug Exposure During Pregnancy |
1.0% |
| Narcolepsy |
0.6% |
| Pain |
0.6% |
| Attention Deficit/hyperactivity Disorder |
0.5% |
| Depression |
0.4% |
| Abnormal Behaviour |
0.3% |
| Acne |
0.3% |
| Anxiety |
0.3% |
| Arthritis |
0.3% |
| Central Nervous System Stimulation |
0.3% |
| Aggression |
0.1% |
| Bipolar Disorder |
0.1% |
|
| Completed Suicide |
18.1% |
| Toxicity To Various Agents |
12.6% |
| Drug Toxicity |
8.2% |
| Overdose |
7.1% |
| Respiratory Arrest |
7.1% |
| Death |
6.0% |
| Drug Abuse |
4.9% |
| Drug Interaction |
3.8% |
| Multiple Drug Overdose |
3.8% |
| Intentional Drug Misuse |
3.3% |
| Lymphocytic Leukaemia |
3.3% |
| Multiple Drug Overdose Intentional |
3.3% |
| Substance Abuse |
3.3% |
| Hypoplastic Right Heart Syndrome |
2.7% |
| Poisoning |
2.7% |
| Cardiac Arrest |
2.2% |
| Cardio-respiratory Arrest |
2.2% |
| Accidental Death |
1.6% |
| Hepatic Steatosis |
1.6% |
| Psychotic Disorder |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.1% |
| Bipolar Disorder |
6.9% |
| Pain |
6.9% |
| Product Used For Unknown Indication |
6.9% |
| Attention Deficit/hyperactivity Disorder |
6.0% |
| Contraception |
5.0% |
| Depression |
5.0% |
| Anxiety |
4.1% |
| Fatigue |
3.2% |
| Ill-defined Disorder |
3.2% |
| Multiple Sclerosis |
3.2% |
| Secondary Progressive Multiple Sclerosis |
3.2% |
| Acne |
2.8% |
| Agitation |
2.8% |
| Headache |
2.8% |
| Psychiatric Symptom |
2.8% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Psychotic Disorder |
2.3% |
| Affective Disorder |
1.8% |
| Crohn's Disease |
1.8% |
|
| Throat Tightness |
14.3% |
| Progressive Multifocal Leukoencephalopathy |
11.1% |
| Jaundice |
7.9% |
| Supraventricular Tachycardia |
6.3% |
| Drug Ineffective |
4.8% |
| Pulmonary Oedema |
4.8% |
| Somnolence |
4.8% |
| Spinal Fracture |
4.8% |
| Stress |
4.8% |
| Vision Blurred |
4.8% |
| Brain Neoplasm |
3.2% |
| Hypoacusis |
3.2% |
| Muscle Contracture |
3.2% |
| Nausea |
3.2% |
| Overdose |
3.2% |
| Pulmonary Embolism |
3.2% |
| Rash |
3.2% |
| Respiratory Arrest |
3.2% |
| Sedation |
3.2% |
| Suicidal Ideation |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
65.0% |
| Drug Use For Unknown Indication |
15.0% |
| Attention Deficit/hyperactivity Disorder |
5.0% |
| Chest Pain |
5.0% |
| Hypertension |
5.0% |
| Smoking Cessation Therapy |
5.0% |
|
| Extrapyramidal Disorder |
40.0% |
| Pulmonary Oedema |
40.0% |
| Therapeutic Response Unexpected |
20.0% |
|
